Automated description from the Alliance of Genome Resources (Release 7.4.0)
Predicted to enable transforming growth factor beta binding activity. Acts upstream of or within several processes, including negative regulation of chondrocyte differentiation; positive regulation of bone resorption; and transforming growth factor beta receptor signaling pathway. Located in extracellular region. Is expressed in several structures, including cardiovascular system; central nervous system; jaw; limb; and respiratory system. Used to study brachyolmia-amelogenesis imperfecta syndrome. Human ortholog(s) of this gene implicated in brachyolmia-amelogenesis imperfecta syndrome and geleophysic dysplasia 3. Orthologous to human LTBP3 (latent transforming growth factor beta binding protein 3).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.